Table 2.
Time- averaged Δ NT-proBNP |
Power for the Δ NT-proBNP Endpoint |
Global Rank Power (RRR* of 20%) |
Power for the Clinical Endpoint with RRR of 20% |
Global Rank Power (RRR of 25% |
Power for Clinical Endpoint with RRR of 25% |
---|---|---|---|---|---|
0.4 SD | 92% | 74% | 21% | 83% | 31% |
0.5 SD | 98% | 86% | 21% | 92% | 31% |
0.6 SD | 99% | 93% | 21% | 97% | 31% |
RRR=relative risk reduction. SD=standard deviation. Δ=difference